Vasodilator therapy for chronic heart failure
Mason, D.T.; Awan, N.A.; Demaria, A.N.; Lee, G.; Joye, J.A.; Amsterdam, E.A.
Comprehensive Therapy 5(7): 6-14
1979
ISSN/ISBN: 0098-8243 PMID: 383392 Document Number: 147803
Document emailed within 1 workday
Related Documents
Ito, T.; Matsumoto, S.; Ito, Y. 1978: Chronic heart failure and vasodilator therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3565-3572Artese, D.; Albani, A.; Di Tomasso, E. 1983: Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution Minerva Medica 74(13): 715-722
Kersting, F.; Samosny, G.; Kasper, W.; Schuster, H.P. 1981: Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure Die Medizinische Welt 32(26): 1040-1045
Francoual, M.; Nitenberg, A. 1980: Alteration in left ventricular function induced by dihydralazine in severe chronic congestive heart failure: limits of vasodilator therapy? La Nouvelle Presse Medicale 9(19): 1384
Corbalán, R.; Kunstmann, S.; Jalil, J. 1993: Vasodilator agents in chronic heart failure: which is the best option? Revista Medica de Chile 121(1): 81-88
Bower, P.J. 1982: Vasodilator therapy in congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 134(2): 36-39
Just, H.; Drexler, H.; Holubarsch, C. 1988: Therapy of heart failure with vasodilator agents Zeitschrift für Kardiologie 77(Suppl 5): 97-101
Katila, M.; Luomanmäki, K. 1980: Vasodilator therapy in congestive heart failure Duodecim; Laaketieteellinen Aikakauskirja 96(5): 430-443
Groden, D.L. 1993: Vasodilator therapy for congestive heart failure. Lessons from mortality trials Archives of Internal Medicine 153(4): 445-454
Mauri, F.; Gronda, E.; Bossi, M.; Rovelli, F. 1980: Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside I.v. and oral prazosin Giornale Italiano di Cardiologia 10(4): 414-423
Cleland, J.G. 1994: Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents? British Journal of Hospital Medicine 52(5): 193; 195-196
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Lloyd, E.A. 1979: The use of vasodilator agents in the treatment of heart failure South African Medical Journal 56(20): 787-795
Pierach, C.A.; Jarosch, P.F. 1974: Treatment of heart failure with vasodilator drugs Münchener Medizinische Wochenschrift 116(39): 1689-1690
Li, L.; Yi, S. 2015: Heart rate reduction is not the therapeutic target in the chronic heart failure therapy Zhonghua Xin Xue Guan Bing Za Zhi 43(3): 197-199
Hoppe, U.C.; Erdmann, E. 1998: Guidelines for therapy of chronic heart failure. German Society of Cardiology-Heart and Cardiovascular Research Zeitschrift für Kardiologie 87(8): 645-658
You, K. 1983: The role of vasodilator agents in the emergency treatment of heart failure Zhonghua Nei Ke Za Zhi 22(2): 111-114
Kuriata, A.V.; Karavanskaia, I.L.; Kushnir, I.S. 2011: The use of metabolic therapy in the treatment of ischemic heart disease in hemodynamically formed insignificant aortic stenosis with chronic heart failure Likars'ka Sprava 2011(7-8): 51-58
Hradec, Jaromír. 2018: Pharmacological therapy for chronic heart failure Vnitrni Lekarstvi 64(9): 853-859
Schneider, J. 1994: Chronic heart failure. Diagnosis and therapy Medizinische Monatsschrift für Pharmazeuten 17(1): 10-14